InsidersTradesSigma
Declaraciones totales
Empresa
▲ Compras (0 oper.)
▼ Ventas (39 oper.)
Historial del iniciado
DirectivoCompras declaradas
0
Ventas declaradas
39
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Discover the full record of transactions filed by Boulding Mark Elliott, Vice-Président Exécutif et Directeur Juridique. Officer active across 1 company, notably PTC Therapeutics, INC.. Cumulatively, 70 reports have been published. Split: 0 buy · 39 sells. Total volume traded: €2.7m. History available since 8 July 2021. The latest transaction was disclosed on 17 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Boulding Mark Elliott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones70 en total
2813 títulos@ 25,69 US$Common StockSEC:0001578852-26-000022:0
1844 títulos@ 72,39 US$Common StockSEC:0001578852-26-000022:1
969 títulos@ 72,90 US$Common StockSEC:0001578852-26-000022:2
601 títulos@ 86,38 US$0.0007% mcap0.8% de su flujoCommon StockSEC:0001578852-26-000020:4
2266 títulos@ 39,42 US$0.0012% mcap1.4% de su flujoCommon StockSEC:0001578852-26-000020:0
313 títulos@ 83,10 US$0.0004% mcap0.4% de su flujoCommon StockSEC:0001578852-26-000020:1
833 títulos@ 84,41 US$0.0009% mcap1.1% de su flujoCommon StockSEC:0001578852-26-000020:2
519 títulos@ 85,84 US$0.0006% mcap0.7% de su flujoCommon StockSEC:0001578852-26-000020:3
2813 títulos@ 46,54 US$0.0018% mcap2.0% de su flujoCommon StockSEC:0001578852-26-000020:5
387 títulos@ 83,10 US$0.0004% mcap0.5% de su flujoCommon StockSEC:0001578852-26-000020:6
1036 títulos@ 84,41 US$0.0012% mcap1.4% de su flujoCommon StockSEC:0001578852-26-000020:7
645 títulos@ 85,84 US$0.0007% mcap0.9% de su flujoCommon StockSEC:0001578852-26-000020:8
745 títulos@ 86,38 US$0.0009% mcap1.0% de su flujoCommon StockSEC:0001578852-26-000020:9
2012 títulosCommon StockSEC:0001578852-26-000018:3
309 títulosCommon StockSEC:0001578852-26-000018:5
8510 títulosCommon StockSEC:0001578852-26-000018:0
6600 títulosCommon StockSEC:0001578852-26-000018:1
1850 títulosCommon StockSEC:0001578852-26-000018:2
1703 títulosCommon StockSEC:0001578852-26-000018:4
2265 títulos@ 39,42 US$1.5% de su flujoCommon StockSEC:0001578852-26-000012:0
822 títulos@ 68,91 US$1.0% de su flujoCommon StockSEC:0001578852-26-000012:1
1443 títulos@ 69,75 US$1.7% de su flujoCommon StockSEC:0001578852-26-000012:2
588 títulos@ 68,54 US$0.5% de su flujoCommon StockSEC:0001578852-26-000010:0
2813 títulos@ 25,69 US$0.9% de su flujoCommon StockSEC:0001578852-26-000008:0
2482 títulos@ 76,56 US$2.3% de su flujoCommon StockSEC:0001578852-26-000006:0
25 de 70 declaraciones
About Boulding Mark Elliott
Boulding Mark Elliott is Executive Vice President and Chief Legal Officer. He has 67 filings in total, all included in the recent sample, and the transactions recorded over the period from 2021-07-12 to 2026-07-08 show sell volume of EUR 2560556, with the dominant transaction nature stated as Disposition. The largest recent filings concern PTC Therapeutics, INC., including EUR 1380075.46731931 on 2025-03-12, EUR 609331.302997165 on 2025-10-07, and EUR 579158.4161537292 on 2025-09-15.
